Nodulocystic Acne: Oral Gugulipid versus Tetracycline
| Autor: | Jaideep Dogra, Devinder Mohan Thappa |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Nodulocystic acne Tetracycline Administration Oral Tetracycline 500 MG Dermatology law.invention Randomized controlled trial Recurrence law Acne Vulgaris Plant Gums Humans Medicine Commiphora Plant Extracts business.industry Follow up studies Percentage reduction General Medicine Surgery Sebum Female business Facial Dermatoses Follow-Up Studies medicine.drug |
| Zdroj: | Scopus-Elsevier |
| ISSN: | 0385-2407 |
| DOI: | 10.1111/j.1346-8138.1994.tb03277.x |
| Popis: | Twenty patients with nodulocystic acne were randomly allocated to one of two treatment schedules: 1) Tetracycline 500 mg or 2) Tab. Gugulipid (equivalent to 25 mg guggulsterone). Both were taken twice daily for 3 months, and both produced a progressive reduction in the lesions in the majority of patients. With tetracycline, the percentage reduction in the inflammatory lesions was 65.2% as compared to 68% with gugulipid; on comparison, this difference was statistically insignificant (P > 0.05). Follow-up at 3 months showed a relapse in 4 cases on tetracyline and 2 cases on gugulipid. An interesting observation was that the patients with oily faces responded remarkably better to gugulipid. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text